Safety and Tolerability of Egalet-002 in Patients With Moderate-to-Severe Chronic Noncancer Pain
Clinical trial NCT02603705 · COMPLETED
Trial details
- NCT number
- NCT02603705
- Sponsor
- Egalet Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2016-03-07
- Primary completion
- 2017-06-15
- Enrollment
- 281
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.